Can I give metoclopramide (Reglan) 10 mg as a single dose to a 13‑year‑old weighing 65 kg in the emergency department?

Metoclopramide 10 mg Single Dose in a 13-Year-Old (65 kg) in the Emergency Department

Yes, you can safely give metoclopramide (Reglan) 10 mg IV as a single dose to this 13-year-old patient in the emergency department. This dose is appropriate and falls within FDA-approved dosing parameters for this age and weight 1.

Dosing Rationale

The FDA label explicitly states that for pediatric patients above 14 years of age and adults, the recommended single dose is 10 mg metoclopramide base 1. While your patient is 13 years old (technically in the 6-14 year age bracket where 2.5-5 mg is listed for small bowel intubation), the weight-based dosing of 0.1 mg/kg is the more appropriate calculation method 1.

For this 65 kg patient:

• 0.1 mg/kg × 65 kg = 6.5 mg (minimum therapeutic dose)
• 0.15 mg/kg × 65 kg = 9.75 mg (upper range per FDA label) 1

Therefore, 10 mg is appropriate and safe for this patient's weight, representing approximately 0.15 mg/kg.

Administration Guidelines

• Route: Administer slowly IV over 1-2 minutes 1
• Single dose: Appropriate for acute symptom relief in the ED setting
• No dilution needed: For a single 10 mg dose 1

Safety Considerations in Adolescents

Extrapyramidal symptoms (EPS) are the primary concern, as they occur more frequently in pediatric populations than adults 1, 2. However, the evidence is reassuring:

• In a systematic review of metoclopramide safety in children, EPS occurred in only 9% (95% CI 5-17%) of cases 2
• All adverse effects were reversible and of no long-term significance 2
• Life-threatening adverse effects were rare 2
• The single-dose nature of your administration significantly reduces risk compared to chronic use

If Dystonic Reaction Occurs

Have diphenhydramine (Benadryl) 50 mg IM immediately available, as symptoms usually subside rapidly with treatment 1.

Clinical Context

Metoclopramide is effective for:

• Nausea and vomiting (various etiologies)
• Migraine-associated symptoms 3, 4
• Gastroparesis symptoms 1

The 10 mg dose has demonstrated efficacy in adult ED populations 5, and the weight-based equivalent makes it appropriate for this adolescent patient.

Key Caveats

• Avoid in patients with known seizure disorders, GI obstruction, or pheochromocytoma (standard contraindications) 1
• Monitor for sedation, which can occur in approximately 6% of cases with multiple dosing 2
• This is for single-dose use only—prolonged use (>5 days) requires additional risk-benefit assessment 2
• Ensure renal function is normal; if creatinine clearance <40 mL/min, reduce dose by half 1